Chimeric antigen receptor T-cell (CAR-T) therapies are standard of care for the treatment of several hematologic malignancies. Although patients receiving CAR-T therapies are frequently hospitalized ...

One concern with in vivo CAR-Ts is the potential insertional mutagenesis of the lentiviral DNA payload, causing secondary ...

ViroCell Biologics ("ViroCell" or the "Company"), a specialist viral vector Contract Development and Manufacturing ...

The CAR T-cell therapy KYV-101 is safe, and showed preliminary signs of efficacy in patients with progressive forms of MS in ...

UAE's Burjeel Holdings has joined forces with US-based non-profit Caring Cross to locally manufacture CAR-T (Chimeric Antigen ...

Chimeric antigen receptor (CAR-T) cell therapy is a rapidly growing frontier in cancer research, with Australian biotech ...

A team of researchers has successfully created more effective immune cells that can fight cancer without damaging healthy ...

CAR T-cell therapy reprograms a patient's immune cells to target and destroy cancer cells, offering a promising treatment for ...

During a live event, Caron A. Jacobson, MD, MMSc, and participants discussed how they decide on therapy for patients with ...

An Emirati oncologist, who went viral in 2020 for deciding to stay in the US to treat Covid patients and not leave, has ...